Physician profile
Isha Ranadive
NPI 1215321757
$11,043.42
in general payments reported to CMS, 2019-2025
29 companies · $1,482 in 2025
The $1,482 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.92 · 2021: $1,751 · 2022: $4,209 · 2023: $2,374 · 2024: $1,214 · 2025: $1,482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,859 · Travel and Lodging: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,859.21 |
| Travel and Lodging | $210.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,597.70 | 2021-2024 | Optis, Cardiomems, Mitraclip |
| Shockwave Medical, INC | $1,438.44 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $1,222.78 | 2021-2025 | Avvigo Guidance System, Rotapro, Watchman Access System |
| Amgen INC. | $840.81 | 2021-2025 | Repatha |
| Abiomed | $745.24 | 2024-2025 | Impella |
| Cardiovascular Systems INC. | $712.39 | 2021-2022 | |
| Artivion, INC. | $651.87 | 2023-2025 | Photofix Decellularized Bovine Pericardium, Amds-Ascyrus Medical, Bioglue Surgical Adhesive |
| Biotronik INC. | $476.64 | 2021-2022 | |
| Teleflex LLC | $403.44 | 2022-2024 | Turnpike, Trapliner, Vascband |
| Novartis Pharmaceuticals Corporation | $361.00 | 2022-2025 | |
| Medtronic, INC. | $292.87 | 2021-2023 | Corevalve Evolut R |
| Terumo Medical Corporation | $268.87 | 2022-2023 | Angio-Seal, Metacross Otw |
| Bard Peripheral Vascular, INC. | $243.94 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $243.77 | 2022-2024 | Lifevest |
| Pfizer INC. | $219.07 | 2019-2024 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $212.19 | 2021-2024 | Andexxa |
| Cardiva Medical, INC. | $172.31 | 2024-2025 | Cardiva Vascade 5f Vcs, Cardiva Vascade 6/7f Vcs, Optowire |
| Chiesi USA, INC. | $166.93 | 2022-2023 | Kengreal |
| Bausch & Lomb Americas INC. | $145.03 | 2022 | |
| Esperion Therapeutics, INC. | $143.96 | 2025 | Nexletol |
| Scpharmaceuticals INC. | $85.89 | 2024-2025 | |
| Philips North America LLC | $72.44 | 2021-2022 | |
| Cordis US Corp. | $67.34 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $66.54 | 2022 | |
| Cagent Vascular INC | $58.25 | 2022 | |
| Novo Nordisk INC | $42.42 | 2024 | Wegovy |
| Kiniksa Pharmaceuticals International, Plc | $34.33 | 2024 | Arcalyst |
| Procyrion, INC. | $32.94 | 2024 | |
| Heartflow, INC. | $24.02 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Isha Ranadive listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.